OligoTune
@oligotune.bsky.social
Redefining cancer immunotherapy with RNA technology.
At OligoTune, we're redefining cancer immunotherapy with RNA technology that reprograms the tumour microenvironment to target resistant tumours. With innovative, patient-centred treatments, we’re bringi
At OligoTune, we're redefining cancer immunotherapy with RNA technology that reprograms the tumour microenvironment to target resistant tumours. With innovative, patient-centred treatments, we’re bringi
If you weren’t working in RNA therapeutics, what other career might you have chosen?
If I weren’t in RNA therapeutics, I might have pursued my initial training as a musician—or, true to my French heritage, opened a bakery or restaurant!
If I weren’t in RNA therapeutics, I might have pursued my initial training as a musician—or, true to my French heritage, opened a bakery or restaurant!
November 25, 2024 at 3:02 PM
If you weren’t working in RNA therapeutics, what other career might you have chosen?
If I weren’t in RNA therapeutics, I might have pursued my initial training as a musician—or, true to my French heritage, opened a bakery or restaurant!
If I weren’t in RNA therapeutics, I might have pursued my initial training as a musician—or, true to my French heritage, opened a bakery or restaurant!
What’s a recent breakthrough or trend in RNA therapeutics that made you feel ‘we’re working at exactly the right time’?
A major trend is the shift in RNA therapeutics from rare diseases to common conditions like cancer, driven by advances in delivery systems and chemical stability.
A major trend is the shift in RNA therapeutics from rare diseases to common conditions like cancer, driven by advances in delivery systems and chemical stability.
November 25, 2024 at 3:02 PM
What’s a recent breakthrough or trend in RNA therapeutics that made you feel ‘we’re working at exactly the right time’?
A major trend is the shift in RNA therapeutics from rare diseases to common conditions like cancer, driven by advances in delivery systems and chemical stability.
A major trend is the shift in RNA therapeutics from rare diseases to common conditions like cancer, driven by advances in delivery systems and chemical stability.
What sets OligoTune apart from other biotech companies in the RNA space?
OligoTune stands out by its pioneering, agile, and innovative approach to designing solutions for cancer patients.
OligoTune stands out by its pioneering, agile, and innovative approach to designing solutions for cancer patients.
November 25, 2024 at 3:02 PM
What sets OligoTune apart from other biotech companies in the RNA space?
OligoTune stands out by its pioneering, agile, and innovative approach to designing solutions for cancer patients.
OligoTune stands out by its pioneering, agile, and innovative approach to designing solutions for cancer patients.
With over 15 years of experience in therapeutic nucleic acid design, Loïc leads the charge in our mission to turn innovative RNA science into real hope for cancer patients. We asked Loïc a few questions to find out more:
November 25, 2024 at 3:02 PM
With over 15 years of experience in therapeutic nucleic acid design, Loïc leads the charge in our mission to turn innovative RNA science into real hope for cancer patients. We asked Loïc a few questions to find out more: